Darin Lippoldt, Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 20,000 shares at $139.86 ($2.8M) on 2024-01-22, disclosed to the SEC on 2024-01-24.
Scheduled sale ($2.8M) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $139.86 | 10,000 | $1.4M | 50.0% |
| 2 | $139.86 | 10,000 | $1.4M | 50.0% |
| Total | $139.86 avg | 20,000 | $2.8M | 100% |
| Filing → |
| NBIX | SELL | 2025-12-10 | $1.4M | — | Filing → |
| NBIX | SELL | 2025-02-14 | $510K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $215K | — | Filing → |